7Baggers

We provide you with 20 years of free, institutional-grade data for TGTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TGTX. Explore the full financial landscape of TGTX stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$672,268
NameActionSharesAvg PriceAmountReported Date
Lonial SagarSale-20,852$32.24$672,2682025-09-12
Lonial SagarGrant, award...etc14,7182025-06-16
HUME DANIELGrant, award...etc14,7182025-06-16
Hoberman KennethGrant, award...etc14,7182025-06-16
Charney Laurence NGrant, award...etc21,4082025-06-16
Echelard YannSale-10,000$36.94$369,4002025-06-16
Echelard YannGrant, award...etc14,7182025-06-16
Power Sean AGrant, award...etc87,5002025-01-30
WEISS MICHAEL SGrant, award...etc750,0002025-01-30
Power Sean ASale-21,358$30.29$647,0192025-01-07
Lonial SagarSale-5,000$30.44$152,2002024-11-12
Charney Laurence NSale-25,000$30.2$754,8752024-11-12
Echelard YannSale-20,000$24.48$489,6002024-11-07
Charney Laurence NGrant, award...etc22,2502024-06-20
Hoberman KennethGrant, award...etc22,2502024-06-20
Echelard YannGrant, award...etc22,2502024-06-20
Lonial SagarGrant, award...etc22,2502024-06-20
Lonial SagarSale-25,933$16.39$425,0422024-06-20
HUME DANIELGrant, award...etc22,2502024-06-20
Lonial SagarSale-5,000$15.94$79,6752024-03-15
Charney Laurence NSale-22,000$15.97$351,3402024-03-13
WEISS MICHAEL SGrant, award...etc1,001,9082024-01-08
Charney Laurence NSale-17,500$19.03$333,0252024-01-08
Power Sean AGrant, award...etc75,0002024-01-05
Power Sean ASale-47,867$16.91$809,4312024-01-05
Hoberman KennethGrant, award...etc20,0002023-09-29
Echelard YannGrant, award...etc20,0002023-09-29
Charney Laurence NGrant, award...etc20,0002023-09-29
HUME DANIELGrant, award...etc20,0002023-09-29
Lonial SagarGrant, award...etc-20,0002023-09-29
WEISS MICHAEL SOpen Market Purchase100,000$10.132023-08-14
Lonial SagarSale-34,854$23.37$814,5382023-06-26
Power Sean ASale-73,647$26.7$1,966,3752023-06-05
WEISS MICHAEL SGrant, award...etc985,0002023-03-14
Power Sean AGrant, award...etc85,0002023-03-14
Echelard YannOpen Market Purchase9,000$10.642023-01-06
Charney Laurence NSale-30,000$11.1$333,0002023-01-06
Charney Laurence NGrant, award...etc43,7322022-07-22
Hoberman KennethGrant, award...etc43,7322022-07-22
Lonial SagarGrant, award...etc43,7322022-07-22
HUME DANIELGrant, award...etc43,7322022-07-22
Echelard YannGrant, award...etc43,7322022-07-22
Power Sean AGrant, award...etc75,0002022-07-22
Power Sean ASale-84,965$19.2$1,631,3282022-01-07
WEISS MICHAEL SSale-68,220$19.2$1,309,8242022-01-07
WEISS MICHAEL SGrant, award...etc56,3942022-01-07
WEISS MICHAEL SGrant, award...etc1,080,7702021-06-22
Power Sean AGrant, award...etc25,0002021-06-22
Hoberman KennethGrant, award...etc20,0002021-06-22
Lonial SagarGrant, award...etc20,0002021-06-22
Echelard YannGrant, award...etc20,0002021-06-22
HUME DANIELGrant, award...etc20,0002021-06-22
Charney Laurence NGrant, award...etc60,0002021-06-22
Power Sean AGrant, award...etc20,0002021-01-04
Echelard YannSale-30,000$40.05$1,201,5002020-12-11
RA CAPITAL MANAGEMENT, L.P.Sale-158,589$25.81$4,092,7382020-09-11
Power Sean AGrant, award...etc250,0002020-07-20
Lonial SagarGrant, award...etc65,0002020-07-02
WEISS MICHAEL SGrant, award...etc1,556,0292020-06-24
HUME DANIELGrant, award...etc15,0002020-06-24
Hoberman KennethGrant, award...etc15,0002020-06-24
Charney Laurence NGrant, award...etc15,0002020-06-24
Echelard YannGrant, award...etc15,0002020-06-24
KENNEDY WILLIAM JAMESGrant, award...etc-15,0002020-06-24
KENNEDY WILLIAM JAMESSale-7,745$18.27$141,5012020-06-24
Login to see more insider transactions
The information provided in this report about TGTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

TG Therapeutics, Inc
(NASDAQ:TGTX) 

TGTX stock logo

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclon...

Founded: 1993
Full Time Employees: 217
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends